CARDIFF ONCOLOGY (CRDF)
$3.80
0.00 (0.00%)
CRDF Stock Quote Delayed 30 Minutes
CRDF Stock Earnings: Cardiff Oncology Misses EPS, Beats Revenue for Q2 2024
CRDF stock results show that Cardiff Oncology missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$3.79
Market Cap
252.79M
PE Ratio
-3.98
EPS
-0.9539
Volume (Avg. Vol.)
701,868
Day's Range
$3.68 - $3.83
52-Week Range
$2.01 - $6.38
Dividend & Yield
N/A (N/A)
